Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

Brahmachari S, Lee S, Kim S, Yuan C, Karuppagounder SS, Ge P, Shi R, Kim EJ, Liu A, Kim D, Quintin S, Jiang H, Kumar M, Yun SP, Kam TI, Mao X, Lee Y, Swing DA, Tessarollo L, Ko HS, Dawson VL, Dawson TM.

Brain. 2019 Aug 1;142(8):2380-2401. doi: 10.1093/brain/awz172.

PMID:
31237944
2.

Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release.

Szot C, Saha S, Zhang XM, Zhu Z, Hilton MB, Morris K, Seaman S, Dunleavey JM, Hsu KS, Yu GJ, Morris H, Swing DA, Haines DC, Wang Y, Hwang J, Feng Y, Welsch D, DeCrescenzo G, Chaudhary A, Zudaire E, Dimitrov DS, St Croix B.

J Clin Invest. 2018 Jul 2;128(7):2927-2943. doi: 10.1172/JCI120481. Epub 2018 Jun 4.

3.

Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice.

Xiong Y, Neifert S, Karuppagounder SS, Liu Q, Stankowski JN, Lee BD, Ko HS, Lee Y, Grima JC, Mao X, Jiang H, Kang SU, Swing DA, Iacovitti L, Tessarollo L, Dawson TM, Dawson VL.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1635-1640. doi: 10.1073/pnas.1712648115. Epub 2018 Jan 31.

4.

Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2.

Ding X, Philip S, Martin BK, Pang Y, Burkett S, Swing DA, Pamala C, Ritt DA, Zhou M, Morrison DK, Ji X, Sharan SK.

Genetics. 2017 Dec;207(4):1335-1345. doi: 10.1534/genetics.117.300357. Epub 2017 Oct 11.

5.

Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature.

Seaman S, Zhu Z, Saha S, Zhang XM, Yang MY, Hilton MB, Morris K, Szot C, Morris H, Swing DA, Tessarollo L, Smith SW, Degrado S, Borkin D, Jain N, Scheiermann J, Feng Y, Wang Y, Li J, Welsch D, DeCrescenzo G, Chaudhary A, Zudaire E, Klarmann KD, Keller JR, Dimitrov DS, St Croix B.

Cancer Cell. 2017 Apr 10;31(4):501-515.e8. doi: 10.1016/j.ccell.2017.03.005.

6.

Impaired Recall of Positional Memory following Chemogenetic Disruption of Place Field Stability.

Zhao R, Grunke SD, Keralapurath MM, Yetman MJ, Lam A, Lee TC, Sousounis K, Jiang Y, Swing DA, Tessarollo L, Ji D, Jankowsky JL.

Cell Rep. 2016 Jul 19;16(3):793-804. doi: 10.1016/j.celrep.2016.06.032. Epub 2016 Jun 30.

7.

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.

Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, Chun S, Sun S, Ling SC, Myers B, Engelhardt J, Katz M, Baughn M, Platoshyn O, Marsala M, Watt A, Heyser CJ, Ard MC, De Muynck L, Daughrity LM, Swing DA, Tessarollo L, Jung CJ, Delpoux A, Utzschneider DT, Hedrick SM, de Jong PJ, Edbauer D, Van Damme P, Petrucelli L, Shaw CE, Bennett CF, Da Cruz S, Ravits J, Rigo F, Cleveland DW, Lagier-Tourenne C.

Neuron. 2016 May 4;90(3):535-50. doi: 10.1016/j.neuron.2016.04.006. Epub 2016 Apr 21.

8.

Chronic centrosome amplification without tumorigenesis.

Vitre B, Holland AJ, Kulukian A, Shoshani O, Hirai M, Wang Y, Maldonado M, Cho T, Boubaker J, Swing DA, Tessarollo L, Evans SM, Fuchs E, Cleveland DW.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6321-30. doi: 10.1073/pnas.1519388112. Epub 2015 Nov 2.

9.

FGF-Regulated ETV Transcription Factors Control FGF-SHH Feedback Loop in Lung Branching.

Herriges JC, Verheyden JM, Zhang Z, Sui P, Zhang Y, Anderson MJ, Swing DA, Zhang Y, Lewandoski M, Sun X.

Dev Cell. 2015 Nov 9;35(3):322-32. doi: 10.1016/j.devcel.2015.10.006.

10.

Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis.

Basheer WA, Harris BS, Mentrup HL, Abreha M, Thames EL, Lea JB, Swing DA, Copeland NG, Jenkins NA, Price RL, Matesic LE.

J Mol Cell Cardiol. 2015 Nov;88:1-13. doi: 10.1016/j.yjmcc.2015.09.004. Epub 2015 Sep 16.

11.

GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling.

Posokhova E, Shukla A, Seaman S, Volate S, Hilton MB, Wu B, Morris H, Swing DA, Zhou M, Zudaire E, Rubin JS, St Croix B.

Cell Rep. 2015 Jan 13;10(2):123-30. doi: 10.1016/j.celrep.2014.12.020. Epub 2014 Dec 31.

12.

COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.

Xu L, Stevens J, Hilton MB, Seaman S, Conrads TP, Veenstra TD, Logsdon D, Morris H, Swing DA, Patel NL, Kalen J, Haines DC, Zudaire E, St Croix B.

Sci Transl Med. 2014 Jun 25;6(242):242ra84. doi: 10.1126/scitranslmed.3008455.

13.

LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.

Smith S, Tripathi R, Goodings C, Cleveland S, Mathias E, Hardaway JA, Elliott N, Yi Y, Chen X, Downing J, Mullighan C, Swing DA, Tessarollo L, Li L, Love P, Jenkins NA, Copeland NG, Thompson MA, Du Y, Davé UP.

PLoS One. 2014 Jan 21;9(1):e85883. doi: 10.1371/journal.pone.0085883. eCollection 2014.

14.

TCreERT2, a transgenic mouse line for temporal control of Cre-mediated recombination in lineages emerging from the primitive streak or tail bud.

Anderson MJ, Naiche LA, Wilson CP, Elder C, Swing DA, Lewandoski M.

PLoS One. 2013 Apr 30;8(4):e62479. doi: 10.1371/journal.pone.0062479. Print 2013.

15.

Mouse endogenous retroviruses can trigger premature transcriptional termination at a distance.

Li J, Akagi K, Hu Y, Trivett AL, Hlynialuk CJ, Swing DA, Volfovsky N, Morgan TC, Golubeva Y, Stephens RM, Smith DE, Symer DE.

Genome Res. 2012 May;22(5):870-84. doi: 10.1101/gr.130740.111. Epub 2012 Feb 23.

16.

Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1.

Berquam-Vrieze KE, Swing DA, Tessarollo L, Dupuy AJ.

Genesis. 2012 Feb;50(2):112-8. doi: 10.1002/dvg.20798. Epub 2012 Jan 6.

17.

Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.

Ramonet D, Daher JP, Lin BM, Stafa K, Kim J, Banerjee R, Westerlund M, Pletnikova O, Glauser L, Yang L, Liu Y, Swing DA, Beal MF, Troncoso JC, McCaffery JM, Jenkins NA, Copeland NG, Galter D, Thomas B, Lee MK, Dawson TM, Dawson VL, Moore DJ.

PLoS One. 2011 Apr 6;6(4):e18568. doi: 10.1371/journal.pone.0018568.

18.

Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.

Smith WW, Liu Z, Liang Y, Masuda N, Swing DA, Jenkins NA, Copeland NG, Troncoso JC, Pletnikov M, Dawson TM, Martin LJ, Moran TH, Lee MK, Borchelt DR, Ross CA.

Hum Mol Genet. 2010 Jun 1;19(11):2087-98. doi: 10.1093/hmg/ddq086. Epub 2010 Feb 25.

19.

The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue.

Bauer GL, Praetorius C, Bergsteinsdóttir K, Hallsson JH, Gísladóttir BK, Schepsky A, Swing DA, O'Sullivan TN, Arnheiter H, Bismuth K, Debbache J, Fletcher C, Warming S, Copeland NG, Jenkins NA, Steingrímsson E.

Genetics. 2009 Oct;183(2):581-94. doi: 10.1534/genetics.109.103945. Epub 2009 Jul 27.

20.

Transgenic rescue of ataxia mice reveals a male-specific sterility defect.

Crimmins S, Sutovsky M, Chen PC, Huffman A, Wheeler C, Swing DA, Roth K, Wilson J, Sutovsky P, Wilson S.

Dev Biol. 2009 Jan 1;325(1):33-42. doi: 10.1016/j.ydbio.2008.09.021. Epub 2008 Sep 27.

21.

dsu functions in a MYO5A-independent pathway to suppress the coat color of dilute mice.

O'Sullivan TN, Wu XS, Rachel RA, Huang JD, Swing DA, Matesic LE, Hammer JA 3rd, Copeland NG, Jenkins NA.

Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16831-6. Epub 2004 Nov 18.

22.

BAC rescue: a tool for functional analysis of the mouse genome.

Swing DA, Sharan SK.

Methods Mol Biol. 2004;256:183-98. No abstract available.

PMID:
15024167
23.

Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice.

Matesic LE, Yip R, Reuss AE, Swing DA, O'Sullivan TN, Fletcher CF, Copeland NG, Jenkins NA.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10238-43. Epub 2001 Aug 14.

24.

A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA.

Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG.

Genomics. 2001 Apr 1;73(1):56-65.

PMID:
11352566
25.

Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice.

Chandler J, Hohenstein P, Swing DA, Tessarollo L, Sharan SK.

Genesis. 2001 Feb;29(2):72-7.

PMID:
11170347
26.

A mutation in Rab27a causes the vesicle transport defects observed in ashen mice.

Wilson SM, Yip R, Swing DA, O'Sullivan TN, Zhang Y, Novak EK, Swank RT, Russell LB, Copeland NG, Jenkins NA.

Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7933-8.

27.

The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice.

Perry WL, Hustad CM, Swing DA, O'Sullivan TN, Jenkins NA, Copeland NG.

Nat Genet. 1998 Feb;18(2):143-6.

PMID:
9462742
28.

Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.

Ceci JD, Patriotis CP, Tsatsanis C, Makris AM, Kovatch R, Swing DA, Jenkins NA, Tsichlis PN, Copeland NG.

Genes Dev. 1997 Mar 15;11(6):688-700.

29.

Coupled site-directed mutagenesis/transgenesis identifies important functional domains of the mouse agouti protein.

Perry WL, Nakamura T, Swing DA, Secrest L, Eagleson B, Hustad CM, Copeland NG, Jenkins NA.

Genetics. 1996 Sep;144(1):255-64.

30.

Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors.

Federspiel MJ, Swing DA, Eagleson B, Reid SW, Hughes SH.

Proc Natl Acad Sci U S A. 1996 May 14;93(10):4931-6.

31.

A transgenic mouse assay for agouti protein activity.

Perry WL, Hustad CM, Swing DA, Jenkins NA, Copeland NG.

Genetics. 1995 May;140(1):267-74.

32.

Hypervariable yellow (Ahvy), a new murine agouti mutation: Ahvy displays the largest variation in coat color phenotypes of all known agouti alleles.

Siracusa LD, Washburn LL, Swing DA, Argeson AC, Jenkins NA, Copeland NG.

J Hered. 1995 Mar-Apr;86(2):121-8.

PMID:
7751596
33.

The murine dilute suppressor gene encodes a cell autonomous suppressor.

Moore KJ, Swing DA, Copeland NG, Jenkins NA.

Genetics. 1994 Oct;138(2):491-7.

34.

Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.

Ceci JD, Kovatch RM, Swing DA, Jones JM, Snow CM, Rosenberg MP, Jenkins NA, Copeland NG, Meisler MH.

Oncogene. 1991 Feb;6(2):323-32.

PMID:
1705690
35.

Interaction of the murine dilute suppressor gene (dsu) with fourteen coat color mutations.

Moore KJ, Swing DA, Copeland NG, Jenkins NA.

Genetics. 1990 Jun;125(2):421-30. Erratum in: Genetics 1990 Sep;126(1):285.

36.

Spontaneous germ line virus infection and retroviral insertional mutagenesis in eighteen transgenic Srev lines of mice.

Spence SE, Gilbert DJ, Swing DA, Copeland NG, Jenkins NA.

Mol Cell Biol. 1989 Jan;9(1):177-84.

37.

Spontaneous germ-line ecotropic murine leukemia virus infection: implications for retroviral insertional mutagenesis and germ-line gene transfer.

Copeland NG, Lock LF, Spence SE, Moore KJ, Swing DA, Gilbert DJ, Jenkins NA.

Prog Nucleic Acid Res Mol Biol. 1989;36:221-34. No abstract available.

PMID:
2544009
38.

Dilute suppressor dsu acts semidominantly to suppress the coat color phenotype of a deletion mutation, dl20J, of the murine dilute locus.

Moore KJ, Seperack PK, Strobel MC, Swing DA, Copeland NG, Jenkins NA.

Proc Natl Acad Sci U S A. 1988 Nov;85(21):8131-5.

39.

The murine dilute suppressor gene dsu suppresses the coat-color phenotype of three pigment mutations that alter melanocyte morphology, d, ash and ln.

Moore KJ, Swing DA, Rinchik EM, Mucenski ML, Buchberg AM, Copeland NG, Jenkins NA.

Genetics. 1988 Aug;119(4):933-41.

Supplemental Content

Loading ...
Support Center